View large More details CCL Featured Stories, Homepage Featured Stories, Special Communication January 2020: Special Communication – Test Changes … was last modified: January 22nd, 2020 by Admin Read More
View large More details CCL Featured Stories, Homepage Featured Stories, Resources, Special Communication October 2019: Changes to Specimen Requirements, Reference Ranges, and Test Builds … was last modified: October 24th, 2019 by Admin Read More
View large More details CCL Featured Stories, Homepage Featured Stories, Resources, Special Communication Changes to Lp-PLA2 Activity Reference Ranges … was last modified: September 3rd, 2019 by Admin Read More
View large More details CCL Featured Stories, Homepage Featured Stories, Resources, Special Communication Update: Changes to Testosterone (Free & Total) Testing and Reporting … was last modified: September 3rd, 2019 by Admin Read More
View large More details CCL Featured Stories, Homepage Featured Stories, Resources, Special Communication Changes to PARNEO, FTESTO … was last modified: August 16th, 2019 by Admin Read More
View large More details CCL Featured Stories, Homepage Featured Stories, Special Communication Changes to NCYTO, URCAT2, MYOSPL, RUFIN, LIVFIB, & AJPWO Testing … was last modified: July 19th, 2019 by Admin Read More
Technical Briefs Beryllium Lymphocyte Proliferation Test (Be-LPT) … was last modified: January 8th, 2020 by Admin Read More
View large More details CCL Featured Stories, Homepage Featured Stories, Resources, Special Communication Changes to UALDOS, TSIG, TRAB … was last modified: June 27th, 2019 by Admin Read More
View large More details CCL Featured Stories, Homepage Featured Stories, Resources, Special Communication May 2019: Changes to Reference Ranges & Test Builds … was last modified: May 21st, 2019 by Admin Read More
View large More details CCL Featured Stories, Homepage Featured Stories, New & Updated Tests, Resources, Test Information CC-SIGN® Pan-Solid Tumor NGS Panel … was last modified: November 4th, 2019 by Admin Read More
